DBICX
Price
$9.91
Change
-$0.01 (-0.10%)
Updated
Feb 21 closing price
Net Assets
169.2M
PATRX
Price
$11.03
Change
-$0.01 (-0.09%)
Updated
Feb 21 closing price
Net Assets
11.37B
Ad is loading...

DBICX vs PATRX

Header iconDBICX vs PATRX Comparison
Open Charts DBICX vs PATRXBanner chart's image
DWS Global Macro C
Price$9.91
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets169.2M
PIMCO All Asset R
Price$11.03
Change-$0.01 (-0.09%)
VolumeN/A
Net Assets11.37B
DBICX vs PATRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBICX vs. PATRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBICX is a Hold and PATRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PATRX has more cash in the bank: 11.4B vs. DBICX (169M). PATRX pays higher dividends than DBICX: PATRX (3.21) vs DBICX (0.93). DBICX was incepted earlier than PATRX: DBICX (24 years) vs PATRX (19 years). PATRX is a more actively managed with annual turnover of: 73.00 vs. DBICX (48.00). PATRX has a lower initial minimum investment than DBICX: PATRX (0) vs DBICX (1000). PATRX annual gain was more profitable for investors over the last year : 6.75 vs. DBICX (5.25). PATRX return over 5 years is better than : 25.86 vs. DBICX (9.97).
DBICXPATRXDBICX / PATRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years19 years-
Gain YTD3.0152.988101%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets169M11.4B1%
Annual Yield % from dividends0.933.2129%
Returns for 1 year5.256.7578%
Returns for 3 years5.863.49168%
Returns for 5 years9.9725.8639%
Returns for 10 years32.0649.1565%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VICR63.6711.81
+22.77%
Vicor Corp
BH234.28-9.72
-3.98%
Biglari Holdings
CHWY35.12-1.81
-4.90%
Chewy
ZNTL2.32-0.15
-6.07%
Zentalis Pharmaceuticals
GV1.56-0.12
-7.14%
Visionary Holdings Inc.